Inventor · disambiguated record
Alcide Barberis
Also filed as: BARBERIS ALCIDE
22 granted patents·10 pending applications·145 citations·filing 1999–2023
95Inventor score
Files withESBATECH ALCON BIOMED RES UNIT7ESBATECH AG6TELORMEDIX SA3AUF DER MAUR ADRIAN2EWERT STEFAN2
Top patents by PatentIndex Score
32 records- 0193US9173935B2Phospholipid drug analogsMAJ ROBERTO·Filed 2011·Granted Nov 3, 2015·39 cites·25 claims
- 0292US8067547B2Stable and soluble antibodies inhibiting TNFαEWERT STEFAN·Filed 2006·Granted Nov 29, 2011·21 cites·41 claims
- 0388US7258986B2Intrabodies with defined framework that is stable in a reducing environment and applications thereofESBATECH AG·Filed 2000·Granted Aug 21, 2007·24 cites·6 claims
- 0486US7902340B2Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALKDELENEX THERAPEUTICS AG·Filed 2007·Granted Mar 8, 2011·9 cites·12 claims
- 0585US9540407B2Phospholipid drug analogsUROGEN PHARMA LTD·Filed 2015·Granted Jan 10, 2017·5 cites·18 claims
- 0685US7258985B2Intrabodies with defined framework that is stable in a reducing environment and applications thereofESBATECH AG·Filed 2000·Granted Aug 21, 2007·14 cites·10 claims
- 0784US9180183B2Phospholipid drug analogsTELORMEDIX SA·Filed 2013·Granted Nov 10, 2015·3 cites·20 claims
- 0882US9050319B2Phospholipid drug analogsTELORMEDIX SA·Filed 2013·Granted Jun 9, 2015·3 cites·4 claims
- 0980US9683034B2Stable and soluble antibodies inhibiting TNFαESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Jun 20, 2017·2 cites·19 claims
- 1078US8945563B2Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALKAUF DER MAUR ADRIAN·Filed 2011·Granted Feb 3, 2015·4 cites·16 claims
- 1178US8853362B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameTISSOT KATHRIN·Filed 2003·Granted Oct 7, 2014·12 cites·9 claims
- 1277US9173936B2Phospholipid drug analogsTELORMEDIX SA·Filed 2013·Granted Nov 3, 2015·3 cites·13 claims
- 1374US7566528B2Method for the identification and/or validation of receptor tyrosine kinase inhibitorsESBATECH AG·Filed 2005·Granted Jul 28, 2009·2 cites·13 claims
- 1471US2020165322A1Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1570US8936785B2scFv antibodies which pass epithelial and/or endothelial layersAUF DER MAUR ADRIAN·Filed 2007·Granted Jan 20, 2015·1 cites·3 claims
- 1663US10570190B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2018·Granted Feb 25, 2020·0 cites·1 claims
- 1763US9315572B2Stable and soluble antibodies inhibiting TNF alphaESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Apr 19, 2016·0 cites·18 claims
- 1862US9518108B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2014·Granted Dec 13, 2016·0 cites·10 claims
- 1962US9512411B2Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALKCELL MEDICA SWITZERLAND AG·Filed 2014·Granted Dec 6, 2016·0 cites·15 claims
- 2061US8691228B2Stable and soluble antibodies inhibiting TNFαESBATECH ALCON BIOMED RES UNIT·Filed 2012·Granted Apr 8, 2014·0 cites·20 claims
- 2159US8389693B2Stable and soluble antibodies inhibiting TNFαEWERT STEFAN·Filed 2011·Granted Mar 5, 2013·0 cites·7 claims
- 2258US10125186B2Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying sameESBATECH ALCON BIOMED RES UNIT·Filed 2016·Granted Nov 13, 2018·0 cites·10 claims
- 2358US2008233110A1Intrabodies with defined framework that is stable in a reducing environment and applications thereofESBATECH AG·Filed 2007·Application pending·0 cites
- 2452US2014234315A1scFv Antibodies Which Pass Epithelial and/or Endothelial LayersESBATECH ALCON BIOMED RES UNIT·Filed 2014·Application pending·0 cites
- 2551US2007149535A1Protein kinase inhibitorsONCALIS AG·Filed 2006·Application pending·0 cites
- 2650US2009029369A1Genetic selection system to identify proteases, protease substrates and protease inhibitorsONCALIS AG·Filed 2005·Application pending·0 cites
- 2750US2006019238A1Method for identifying protein-protein interactionsESBATECH AG·Filed 2003·Application pending·0 cites
- 2849US2006068388A1Method for the identification of modulators of a secretase activityESBATECH AG·Filed 2002·Application pending·0 cites
- 2945US2025320282A1Anti-allergen antibodies and uses thereofMABYLON AG·Filed 2023·Application pending·0 cites
- 3043US2012003298A1Methods for inducing an immune responseBARBERIS ALCIDE·Filed 2011·Application pending·0 cites
- 3137US6821728B1Screening systemUNIV ZUERICH·Filed 1999·Granted Nov 23, 2004·3 cites·14 claims
- 3235US2012083473A1Treatment of conditions by toll-like receptor modulatorsHOLLDACK JOHANNA·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →